Giovanna Mallucci, MD, PhD

Altos Labs · company speakers →

Untreatable neurodegenerative disorders are an ever-increasing problem as society ages. This talk will focus on how increasing neuronal resilience and functional rejuvenation can slow and prevent these diseases. The speaker will discuss their discoveries on dysregulated PERK-UPR signaling in mediating neurodegeneration and how small molecules and drugs targeting the pathway prevent it. The speaker will also show how they used the biology of hibernation to drive synapse regeneration for neuroprotection via the cold shock protein, RBM3, and how they are translating these approaches to treat dementia.

healthcare-servicespharma-biotech

Is this you? Claim this profile →

No public contact links on file.

Speaking history

Neuroscience

13 November 2027 Chicago, United States “Mechanisms to Medicines in Neurodegeneration”

Neuroscience

11 November 2028 San Diego, United States “Mechanisms to Medicines in Neurodegeneration”

Neuroscience

14 November 2026 Washington, United States “Mechanisms to Medicines in Neurodegeneration”

Topics this speaker covers

healthcare-servicespharma-biotech

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →